Article: Paradigm Genetics Enters Into Collaboration Agreement For Gene Function Research.

RESEARCH TRIANGLE PARK, N.C., Jan. 24 /PRNewswire/ -- Paradigm Genetics, Inc. (Paradigm) has signed a broad collaboration agreement with Monsanto Company in the field of functional genomics. Under the terms of the agreement, Paradigm will develop functional genomics data by analyzing the product of Monsanto's gene sequencing, bioinformatics and functional genomics research, creating a product discovery platform for commercialization. Under terms of the agreement, Paradigm will receive $55 million in committed payments. Additional financial terms were not disclosed.

Paradigm brings to this collaboration its expertise in gene function analysis and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!